In addition, Fitch assigned its “A-” issuer default rating to CMH.
The upgrade and affirmation are a result of several factors, including CMH’s leading market position, solid patient volume growth, robust operating margins and strong liquidity position. Additionally, Fitch positively viewed CMH’s clinical affiliation with Portland-based Oregon Health and Sciences University.
The outlook is stable.
More articles on healthcare finance:
10 hospitals seeking RCM talent
For-profit hospital stock report: Week of May 21-25
Healthcare spending reduced when people get help with social needs, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
